Gerresheimer AG (GXI) Receives €72.64 Consensus Price Target from Analysts

Shares of Gerresheimer AG (ETR:GXI) have been assigned a consensus rating of “Hold” from the eleven analysts that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is €72.64 ($86.48).

A number of equities research analysts have commented on the stock. Credit Suisse Group set a €80.00 ($95.24) price objective on shares of Gerresheimer and gave the company a “buy” rating in a research report on Tuesday, October 10th. Goldman Sachs Group set a €69.50 ($82.74) price objective on shares of Gerresheimer and gave the company a “neutral” rating in a research report on Thursday, October 12th. Hauck & Aufhaeuser set a €63.50 ($75.60) target price on shares of Gerresheimer and gave the company a “neutral” rating in a research report on Thursday, September 21st. set a €65.00 ($77.38) target price on shares of Gerresheimer and gave the company a “neutral” rating in a research report on Tuesday, October 17th. Finally, Berenberg Bank set a €75.00 ($89.29) target price on shares of Gerresheimer and gave the company a “buy” rating in a research report on Monday, September 4th.

Shares of Gerresheimer (ETR:GXI) traded up €0.03 ($0.04) during trading hours on Monday, hitting €68.59 ($81.65). 79,860 shares of the company’s stock were exchanged, compared to its average volume of 100,171. Gerresheimer has a 52 week low of €59.97 ($71.39) and a 52 week high of €78.25 ($93.15).

WARNING: This piece was first published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this piece on another site, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.thelincolnianonline.com/2017/12/08/gerresheimer-ag-gxi-receives-72-64-consensus-price-target-from-analysts.html.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply